Table 1 Subjects’ baseline characteristics
Total | Women | Men | ||||
|---|---|---|---|---|---|---|
Placebo | MFGM | Placebo | MFGM | Placebo | MFGM | |
(n = 22) | (n = 22) | (n = 11) | (n = 11) | (n = 11) | (n = 11) | |
Age, years | 59.0 ± 1.4 | 57.6 ± 1.2 | 59.5 ± 2.0 | 57.9 ± 1.7 | 58.5 ± 2.1 | 57.3 ± 1.7 |
Height, cm | 160.7 ± 1.8 | 161.2 ± 2.1 | 153.9 ± 1.6 | 153.7 ± 2.1 | 167.5 ± 1.2 | 168.6 ± 1.9 |
Body weight, kg | 62.3 ± 2.2 | 59.9 ± 2.3 | 55.2 ± 1.7 | 53.8 ± 3.0 | 69.5 ± 2.6 | 66.1 ± 2.2 |
Body mass index | 24.0 ± 0.6 | 23.0 ± 0.7 | 23.3 ± 0.7 | 22.8 ± 1.3 | 24.8 ± 1.0 | 23.3 ± 0.7 |
Knee extension, kg | 34.0 ± 3.1 | 36.4 ± 3.1 | 23.4 ± 1.4 | 25.5 ± 2.6 | 44.7 ± 4.1 | 47.4 ± 3.0 |
Leg extension, Nm | 100.8 ± 7.8 | 101.1 ± 8.4 | 70.7 ± 5.5 | 71.5 ± 6.5 | 130.9 ± 6.9 | 130.7 ± 8.9 |
Systolic BP, mmHg | 122.3 ± 3.6 | 124.0 ± 4.8 | 118.1 ± 4.1 | 118.3 ± 3.0 | 126.5 ± 5.9 | 129.7 ± 9.0 |
Diastolic BP, mmHg | 76.4 ± 2.9 | 76.4 ± 2.8 | 69.8 ± 3.1 | 69.0 ± 2.3 | 82.9 ± 4.0 | 83.7 ± 4.2 |